In the modern research, we claimed the identification and also the characterization of a fresh atypical opioid receptor with exceptional detrimental regulatory Attributes in the direction of opioid peptides.1 Our benefits confirmed that ACKR3/CXCR7, hitherto often called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is usually a